THE CLINICAL IMPLICATION OF THE ACTIVATION OF NF-κB SIGNALING PATHWAY IN DIFFUSE LARGE B CELL LYMPHOMA: PRE- AND POST-RITUXIMAB ERA

被引：0
|
作者：
Lee, L. [1 ]
Liu, J. H. [2 ]
Tzeng, C. H. [2 ]
Gau, J. P. [2 ]
Chen, P. M. [2 ]
Chiou, T. J. [2 ]
机构：
[1] Vet Gen Hosp Taipei, Taoyuan Branch, Hematol Oncol, Taipei, Taiwan
[2] Vet Gen Hosp Taipei, Hematol Oncol, Taipei, Taiwan
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E975
引用
收藏
页码：390 / 391
页数：2
相关论文
共 50 条
  • [1] Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era
    Jin, Jia
    Gui, Ailing
    Chen, Guangliang
    Liu, Yizhen
    Xia, Zuguang
    Liu, Xiaojian
    Lv, Fangfang
    Cao, Junning
    Hong, Xiaonan
    Yang, Ling
    Gu, Juan J.
    Zhang, Qunling
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (03) : 372 - 380
  • [2] Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era
    Jia Jin
    Ailing Gui
    Guangliang Chen
    Yizhen Liu
    Zuguang Xia
    Xiaojian Liu
    Fangfang Lv
    Junning Cao
    Xiaonan Hong
    Ling Yang
    Juan J. Gu
    Qunling Zhang
    International Journal of Hematology, 2022, 116 : 372 - 380
  • [3] Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab
    Tai, W. M.
    Chung, J.
    Tang, P. L.
    Koo, Y. X.
    Hou, X.
    Tay, K. W.
    Quek, R.
    Tao, M.
    Lim, S. T.
    ANNALS OF HEMATOLOGY, 2011, 90 (07) : 809 - 818
  • [4] Survival in Advanced Diffuse Large B-Cell Lymphoma in Pre- and Post-rituximab Eras in the United States
    Shah, Binay Kumar
    Bista, Amir
    Shafii, Bahman
    ANTICANCER RESEARCH, 2014, 34 (09) : 5117 - 5120
  • [5] Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab
    W. M. Tai
    J. Chung
    P. L. Tang
    Y. X. Koo
    X. Hou
    K. W. Tay
    R. Quek
    M. Tao
    S. T. Lim
    Annals of Hematology, 2011, 90 : 809 - 818
  • [6] Activation of the NF-κB signalling pathway in diffuse large B-cell lymphoma:: clinical implications
    Espinosa, I.
    Briones, J.
    Bordes, R.
    Brunet, S.
    Martino, R.
    Sureda, A.
    Sierra, J.
    Prat, J.
    HISTOPATHOLOGY, 2008, 53 (04) : 441 - 449
  • [7] Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era
    Beygi, Sara
    Sadashiv, Santhosh
    Reilly, James B.
    Khan, Cyrus
    Lister, John
    LEUKEMIA & LYMPHOMA, 2018, 59 (12) : 2847 - 2861
  • [8] Survival In Advanced Diffuse Large B-Cell Lymphoma In Pre- and Post-Rituximab Eras In The United States: A Population Based Study
    Bista, Amir
    Shafii, Bahman
    Shah, Binay K.
    BLOOD, 2013, 122 (21)
  • [9] Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era
    Dalia, Samir
    Chavez, Julio
    Little, Bryan
    Bello, Celeste
    Fisher, Kate
    Lee, Ji-Hyun
    Chervenick, Paul
    Sokol, Lubomir
    Sotomayor, Eduardo
    Shah, Bijal
    ANNALS OF HEMATOLOGY, 2014, 93 (08) : 1305 - 1312
  • [10] Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era
    Samir Dalia
    Julio Chavez
    Bryan Little
    Celeste Bello
    Kate Fisher
    Ji-Hyun Lee
    Paul Chervenick
    Lubomir Sokol
    Eduardo Sotomayor
    Bijal Shah
    Annals of Hematology, 2014, 93 : 1305 - 1312
12345